APL Swift Services (Malta) Ltd. Oy Medfiles Ltd. SPECIAL PRODUCTS LINE S.p.A.
PolandAll drugs from this manufacturer
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disorders occurring in asthma.
Dosage form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 micrograms/dose fluticasone propionate 100 micrograms/dose ATC: R03AK06
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing disorders occurring in asthma.
Dosage form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 micrograms/dose fluticasone propionate 250 micrograms/dose ATC: R03AK06
-
The medicine is used in adults and adolescents over 12 years of age to prevent breathing difficulties occurring in asthma or chronic obstructive pulmonary disease (COPD).
Dosage form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 micrograms/dose fluticasone propionate 500 micrograms/dose ATC: R03AK06